SAGE Therapeutics Receives $20,000,000 Series B Financing Round

  • Feed Type
  • Date
    10/16/2013
  • Company Name
    SAGE Therapeutics
  • Mailing Address
    215 First Street Cambridge, MA 02142
  • Company Description
    SAGE Therapeutics’ mission is to make life better for patients with nervous systems diseases by discovering, developing, and delivering important new medicines to the market.
  • Website
    http://www.sagerx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B financing will accelerate clinical and preclinical efforts to continue to advance SAGE’s pipeline programs in CNS disorders.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Third Rock Ventures